Eyenovia Q3 EPS $(0.21) Misses $(0.20) Estimate

Eyenovia (NASDAQ:EYEN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is unchanged from the same period last year.

byBenzinga Newsdesk

November 10, 2022

1 minute read

Eyenovia (NASDAQ:EYEN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.20) by 5 percent. This is unchanged from the same period last year.

Jazz Caregiver Survey: CBD-Based Epidiolex Improves Seizure & Non-Seizure Outcomes In Patients With Severe Epilepsy

By Vuk Zdinjak

Today, 4:25 AM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced new real-world data from the BECOME (BEhavior, COgnition, and More with Epidiolex) caregiver survey that showed a substantial proportion of caregivers of adult and pediatric

JAZZ

Morgan Stanley Maintains Equal-Weight on Range Resources, Raises Price Target to $16

By Benzinga Newsdesk

Today, 4:25 AM

Morgan Stanley analyst Devin McDermott maintains Range Resources (NYSE:RRC) with a Equal-Weight and raises the price target from $12 to $16.

RRC

Earnings

Return on Capital Employed Overview: Korn Ferry

By Benzinga Insights

Today, 4:25 AM

After pulling data from Benzinga Pro it seems like during Q4, Korn Ferry (NYSE:KFY) earned $86.25 million, a 32.38% increase from the preceding quarter. Korn Ferry also posted a total of $557.39 million in sales, a 16.64% increase since Q3.

KFY